McCarthy Consultant Services Inc

Quantum Allergy Canada, based in Newmarket, ON, specializes in providing services related to allergies. With a focus on delivering solutions for allergy-related concerns, they offer a range of services to help individuals manage and alleviate allergic reactions. Using their expertise and knowledge in the field, Quantum Allergy Canada aims to assist clients in identifying and addressing various allergy triggers. By offering personalized approaches and tailored solutions, they strive to help individuals lead healthier, more comfortable lives. Generated from the website content

Associated National Brokerage (ANB) Canada, founded in 1995 and located in Markham, Ontario, has established itself as a trusted full-service partner in the Over The Counter (OTC), Sports Nutrition, Health and Beauty Aid (HABA), and prescription (RX) industries. With over 30 years of experience, ANB provides comprehensive support in warehousing, distribution, sales, marketing, and regulatory compliance, ensuring the success of both international and domestic brands in the Canadian market. ANB's dedicated team works closely with clients to deliver expert insights in logistics, data analytics, and market strategy, while actively pursuing growth opportunities across various retail channels. Their commitment to client success is reflected in their tailored approach, where every client receives unwavering dedication regardless of size, propelling them to new levels of achievement. Generated from the website

BirchBioMed Inc. is a pioneering clinical-stage biopharmaceutical company based in King, Ontario, focused on developing innovative treatments for diseases with high unmet medical needs, including organ fibrosis, scarring skin disorders, and specific autoimmune conditions like Type 1 Diabetes. Leveraging groundbreaking technologies licensed from the University of British Columbia, the company is committed to transforming patient care with advanced therapies poised to set new standards in medical treatment, pending regulatory approvals. With a robust portfolio of therapies in mid to late-stage clinical trials, BirchBioMed is addressing critical healthcare challenges through its unique applications of Kynurenic Acid (KynA) in both topical creams and systemic administration. The company's commitment to pioneering advanced therapeutic strategies offers new hope for improving patient outcomes across a spectrum of life-altering conditions, from idiopathic pulmonary fibrosis to autoimmune disorders. Generated from the website